Financials
Financial year 2025
DEWAEL RX from Gesves, company number BE0635804118, closed financial year 2025 with a result of € 226,438 after tax. For that financial year DEWAEL RX recorded a gross margin of € 324,838 and equity of € 19,003. Compared with financial year 2024, the result moved from € 267,713 to € 226,438. The company is profitable. The buffer shrank hard: equity is 82 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 19,003
▼ 82% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 226,438
▼ 15% vs 2024
Profit after tax over the fiscal year.
€ 323,290
▲ 243% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 316,012 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 30,548
▼ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 11,846
▼ 65% vs 2024
Loans from banks and other lenders, long and short.
€ 3,381
▲ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,276
▲ € 4,477 vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 210,659 | € 286,286 | € 306,163 | € 324,838 | ▲ 6% |
| Profit after taxes | € 148,685 | € 201,725 | € 267,713 | € 226,438 | ▼ 15% |
| Equity | € 20,863 | € 20,863 | € 108,576 | € 19,003 | ▼ 82% |
| Total debts | € 270,792 | € 335,351 | € 220,592 | € 486,915 | ▲ 121% |
| Cash | € 80,167 | € 135,325 | € 94,134 | € 323,290 | ▲ 243% |
| Retained profit | € 2,263 | € 2,263 | € 89,976 | € 403 | ▼ € 89,573 |
| Dividend | € 148,685 | € 201,725 | € 180,000 | € 316,012 | ▲ 76% |
| Bank debt | € 68,551 | € 51,307 | € 33,835 | € 11,846 | ▼ 65% |
| Balance sheet total | € 291,654 | € 356,214 | € 329,168 | € 505,917 | ▲ 54% |
Key figures of DEWAEL RX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DEWAEL RX?
What happened at DEWAEL RX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 226,438 (▼ 15% vs 2024). Source: NBB ↗
- New establishment in Gesves. KBO
- Start of the company according to the CBE. KBO
In short
From € 148,685 profit in 2022 to € 226,438 profit in 2025.
Paid € 241,423 in corporate taxes since 2022.
Best year ever: 2024, with € 267,713 profit.
Paid out € 846,422 in dividends to the owners in total.
Management
Behind DEWAEL RX is Stéphanie Dewael. It owns 12.5% of Centre d'Imagerie Médical de Gembloux itself.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Fau Sainte-Anne 36
5340 Gesves
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0635.804.118
- VAT number
- BE 0635.804.118
- Registered office
- Fau Sainte-Anne 36, 5340 Gesves
- Names & denominations
- DEWAEL RX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 August 2015
- Peppol
- Active · Active since 10 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten